Bristol-Myers Squibb
- A01 - Preparados estomatológicos
- KENALOG IN ORABASE oromucosal paste 0.1%
- A07 - Antidiarreicos, antiinfecciosos y antiinflamatorios intestinales
- MYCOSTATIN oral suspension 100 000 IU/ml
- B01 - Agentes antitrombóticos
- COUMADIN tablet 10 mg
- COUMADIN tablet 2 mg
- COUMADIN tablet 2.5 mg
- COUMADIN tablet 5 mg
- COUMADIN tablet 7.5 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- CAPOZIDE tablet 50 mg+25 mg
- H02 - Corticosteroides para uso sistémico
- KENACORT A suspension for injection 40 mg/1 ml
- J01 - Antibacterianos para uso sistémico
- CEFZIL film-coated tablet 250 mg
- CEFZIL film-coated tablet 500 mg
- CEFZIL powder for oral suspension 125 mg/5 ml
- CEFZIL powder for oral suspension 250 mg/5 ml
- MAXIPIME powder for solution for injection 1 g
- MAXIPIME powder for solution for injection 2 g
- ULTRACEF capsule, hard 500 mg
- ULTRACEF powder for oral suspension 250 mg/5 ml
- ULTRACEF powder for oral suspension 500 mg/5 ml
- J05 - Antivirales de uso sistémico
- BARACLUDE film-coated tablet 0.5 mg
- BARACLUDE film-coated tablet 1 mg
- REYATAZ capsule, hard 150 mg
- REYATAZ capsule, hard 200 mg
- ZERIT capsule, hard 20 mg
- ZERIT capsule, hard 30 mg
- ZERIT capsule, hard 40 mg
- L01 - Antineoplásicos
- SPRYCEL film-coated tablet 20 mg
- SPRYCEL film-coated tablet 50 mg
- SPRYCEL film-coated tablet 70 mg
- VEPESID capsule, soft 100 mg
- VEPESID concentrate for solution for infusion 100 mg/5 ml
- L04 - Inmunosupresores
- ORENCIA powder for solution for infusion 250 mg
- N02 - Analgésicos
- PERFALGAN solution for infusion 1 g/100 ml
- N05 - Psicolépticos
- ABILIFY tablet 10 mg
- ABILIFY tablet 15 mg